Physician profile
Gerald L Devaughn
NPI 1578636072
$1,578.89
in general payments reported to CMS, 2019-2025
18 companies · $60.30 in 2025
The $60.30 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $730 · 2020: $135 · 2021: $204 · 2022: $163 · 2023: $199 · 2024: $87.85 · 2025: $60.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $347.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $347.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $186.17 | 2021 | |
| Edwards Lifesciences Corporation | $151.10 | 2019 | |
| Medtronic Vascular, INC. | $146.21 | 2019 | |
| Janssen Pharmaceuticals, INC | $136.67 | 2020-2024 | Xarelto |
| Regeneron Pharmaceuticals, INC. | $133.00 | 2023 | |
| Amarin Pharma, INC. | $132.48 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.92 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $110.53 | 2022 | |
| Novartis Pharmaceuticals Corporation | $87.89 | 2019-2021 | |
| Akcea Therapeutics, INC. | $66.04 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $60.30 | 2025 | Assure Wcd |
| Amgen INC. | $57.78 | 2019-2020 | |
| Boston Scientific Corporation | $47.43 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $34.49 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $30.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $26.10 | 2019 | |
| Pfizer INC. | $25.69 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $17.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Devaughn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.